Amid New M&A Rumors, Amarin CEO Focused On Vascepa Approval

Pfizer and Gilead Seen As Suitors

 
• By Andrew McConaghie

 John Thero insists company is focused on approval and launch, as interest in European rights grow.

Computer_Screen
Takeover chatter has increased since Novartis pounced for The Medicines Company

More from Business

More from Scrip